XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 4,102 $ 5,469
General and administrative 3,800 4,164
Total operating expenses 7,902 9,633
Loss from operations (7,902) (9,633)
Other income (expense):    
Grant income   12
Interest income 320 711
Interest expense (646) (609)
Change in fair value of warrant liability 7 724
Total other income (expense), net (319) 838
Net loss and comprehensive loss $ (8,221) $ (8,795)
Net loss per share - basic $ (0.28) $ (0.3)
Net loss per share - diluted $ (0.28) $ (0.3)
Weighted-average common shares outstanding, basic 29,197,537 28,919,810
Weighted-average common shares outstanding, diluted 29,197,537 28,919,810